Abstract
Due to population ageing and increasing life expectancy, aortic stenosis (AS) has become the most common valvular heart disease. Transcatheter aortic valve implantation (TAVI) is currently indicated in elderly patients with severe symptomatic aortic stenosis at high surgical risk (STS-PROM/EuroSCORE II >8%). Thе comparative clinical outcomes of surgical aortic valve replacement (SAVR) and TAVI are provided in this paper. Despite being minimally invasive, TAVI is associated with plenty of complications including bleeding, stroke, vascular injury, arrhythmias, need for a pacemaker due to conduction disturbances, and infective endocarditis characterized by an extremely high mortality. This article summaries current data on the prevalence, risk factors, microbiological profile, clinical outcomes as well as diagnosis and management of infective endocarditis related to TAVI. A clinical case of SAVR after TAVI-IE is described in details. Besides, the main clinical, anatomical and procedural factors that influence the choice of treatment for AS are also presented.
References
- Dzhidzalova D.Kh., Berdibekov B.Sh., Petrosian K.V. Transcatheter aortic valve replacement: from previously inoperable patients to low surgical risk patients. Creative Cardiology. 2021; 15 (4): 440–55 (in Russ.). DOI: 10.24022/1997-3187-2021-15-4-440-455
- Donato M., Ferri N., Lupo M.G., Faggin E., Rattazzi M. Current evidence and future perspectives on pharmacological treatment of calcific aortic valve stenosis. Int. J. Mol. Sci. 2020; 21(21): 8263. DOI: 10.3390/ijms21218263
- Titov D.A., Salokhiddinov M.A., Muratov R.M. Repeated surgical interventions on heart valves in elderly patients. Russian Journal Thoracic and Cardiovascular Surgery. 2021; 63 (2): 91–8 (in Russ.). DOI: 10.24022/0236-2791-2021-63-2-91-98
- Vipparthy S.C., Ravi V., Avula S., Kambhatla S., Mahmood M., Kabour A. et al. Meta-analysis of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with low surgical risk. Am. J. Cardiol. 2020; 125 (3): 459–68. DOI: 10.1016/j.amjcard.2019.10.036
- Swift S.L., Puehler T, Misso K., Lang S.H., Forbes C., Kleijnen J. Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis: a systematic review and meta-analysis. BMJ Open. 2021; 11 (12): e054222. DOI: 10.1136/bmjopen-2021-054222
- Kranin D.L., Gaydukov A.V., Nazarov D.A., Dunayev E.P., Varochkin K.A., Fedorov A.Yu. Conduction disorders after transcatheter aortic valve implantation. Ann. Aritmol. 2018; 15 (1): 4–11 (in Russ.). DOI: 10.15275/annaritmol.2018.1.1
- Østergaard L., Lauridsen T.K., Iversen K., Bundgaard H., Søndergaard L., Ihlemann N. et al. Infective endocarditis in patients who have undergone transcatheter aortic valve implantation: a review. Clin. Microbiol. Infect. 2020; 26 (8): 999–1007. DOI: 10.1016/j.cmi.2020.01.028
- Tinica G., Tarus A., Enache M., Artene B., Rotaru I., Bacusca A. et al. Infective endocarditis after TAVI: a meta-analysis and systematic review of epidemiology, risk factors and clinical consequences. Rev. Cardiovasc. Med. 2020; 21 (2): 263–74. DOI: 10.31083/j.rcm.2020.02.68
- Kuttamperoor F., Yandrapalli S., Siddhamsetti S., Frishman W.H., Tang G.H.L. Infectious endocarditis after transcatheter aortic valve replacement epidemiology and outcomes. Cardiol. Rev. 2019; 27 (5): 236–41. DOI: 10.1097/CRD.0000000000000244
- Khan A., Aslam A., Satti K.N., Ashiq S. Infective endocarditis post-transcatheter aortic valve implantation (TAVI), microbiological profile and clinical outcomes: A systematic review. PLoS One. 2020; 15 (1): e0225077. DOI: 10.1371/journal.pone.0225077
- Habib G., Lancellotti P., Antunes M.J., Bongiorni M.G., Casalta J.P., Zotti F.D. et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC) Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur. Heart J. 2015: 36 (44): 3075– 128. DOI: 10.1093/eurheartj/ehv319
- Aslanidis I.P., Pursanova D.M., Mukhortova O.V., Shurupova I.V., Katunina T.A., Serguladze S.Yu. et al. 18F-fluorodeoxyglucose PET/CT in diagnostics of infective endocarditis of native valve. REJR. 2019; 9 (4): 68–76 (in Russ.). DOI: 10.21569/2222-7415-2019- 9-4-68-76
- Zakhour J., Allaw F., Kalash S., Wehbe S., Kanj S.S. Infective endocarditis after transcatheter aortic valve replacement: challenges in the diagnosis and management. Pathogens. 2023; 12 (2): 255. DOI: 10.3390/pathogens12020255
- Vahanian A., Beyersdorf F., Praz F., Milojevic M., Baldus S., Bauersachs J. et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur. Heart J. 2022; 43 (7): 561–632. DOI: 10.1093/eurheartj/ehab395
- Babeshko S.S., Barbukhatti K.O., Shumkov D.I., Samurganov Yu.P. Surgery for endocarditis after transcatheter aortic valve implantation. Russian Journal of Thoracic and Cardiovascular Surgery. 2020; 62 (6): 602–6 (in Russ.). DOI: 10.24022/0236-2791-2020-62-6-602-606
About the authors
- Anait K. Margaryan, Clinical Resident; ORCID
- Irina I. Averina, Dr. Med. Sci., Professor, Senior Researcher, Cardiologist; ORCID
- Dmitry S. Troshin, Clinical Resident; ORCID
- Zamik F. Fatulaev, Cand. Med. Sci., Leading Researcher, Cardiovascular Surgeon; ORCID
- Sergey A. Donakanyan, Dr. Med. Sci., Professor, Cardiovascular Surgeon; ORCID
- Leo A. Bockeria, Academician of RAS, President of the Center;ORCID
